Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Oncofetal reprogramming of the tumor vasculature

ABSTRACT: Oncofetal reprogramming of the tumor vasculature

PROVIDER: PRJNA1027431 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR26372002_1.fastq.gz	Fastqsanger.gz
	SRR26372002_2.fastq.gz	Fastqsanger.gz
	SRR26372003_1.fastq.gz	Fastqsanger.gz
	SRR26372003_2.fastq.gz	Fastqsanger.gz
	SRR26372004_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 26

Similar Datasets

Vaccination against oncofetal targets in the tumor vasculature

Project description:Vaccination against oncofetal targets in the tumor vasculature

| PRJNA1191492 | ENA

Oncofetal reprogramming of the tumor vasculature

Project description:Certain embryonic genes, such as carcinoembryonic antigens (CEA) and oncofetal antigens, become re-expressed in malignant transformation and we hypothesized that a similar phenomenon features tumor endothelial cells as well. Therefore, we performed a systematic search for mouse embryo-specific gene expression at days E11 and E18 in comparison to adult mouse and queried for overexpression of these genes in sorted murine tumor endothelial cells.

2025-04-09 | GSE245218 | GEO

Oncofetal reprogramming drives phenotypic plasticity in WNT-dependent colorectal cancer

Project description:Oncofetal reprogramming drives phenotypic plasticity in WNT-dependent colorectal cancer

| PRJNA997295 | ENA

Vaccination against oncofetal targets in the tumor vasculature

Project description:Mice were vaccinated with iBoost technology against a tumor vascular target, prior to B16F10 or CT26 tumor inoculation. Tumors from control and target vaccinated mice were excised and subject to RNAseq

2025-04-09 | GSE283041 | GEO

Effects of a vaccine against the tumor vasculature

Project description:Effects of a vaccine against the tumor vasculature

| PRJNA723195 | ENA

Heterogeneity of Breast Cancer Vasculature

Project description:Tumor-associated breast vasculature was laser-cappture microdissected from IDC breast cancer cases. The goal of the study was to characterize the heterogeneity of breast tumor-associated vasculature and identify gene expression signatures predictive of clinical outcome. common reference design, 32 samples

2010-09-19 | E-GEOD-15363 | biostudies-arrayexpress

Zebrafish functional xenograft vasculature platform identifies PF-502 as a durable vasculature normalization drug

Project description:Tumor vasculature are structurally chaotic and functionally inefficient. Restoring aberrant tumor blood vessels, or “normalize” the tumor vasculature can alleviate hypoxia and enhance intra-tumoral drug delivery. However, identifying tumor vascular normalizing drugs are currently hampered by an absence of efficient screening platform. We aimed to develop a robust method to visualize, digitalize and evaluate the structural and functional changes of tumor vasculature in batch: zebrafish functional xenograft vasculature platform (zFXVP). As proof of principle, we applied zFXVP to a small compound library which has been implicated in affecting the morphology of tumor vasculature. zFXVP identified PF-502 as a durable tumor vascular normalization agent. Further molecular analysis using RNA-Seq, pharmaceutical inhibition and gene knockout indicate PF-502 can induce endothelial cell cycle arrest and simplify redundant tumor vasculature by blocking PI3K/mTOR signaling and stabilize the vessel lumen and stimulate the blood function by activating Notch1 signaling with mediating S3 cleavage. Last, in mouse tumor xenograft model, PF-502 reproduced a potent vascular normalizing effect at a sub MTD (maximum tolerated dose) and showed its ability to improve intra-tumoral drug delivery and synergize chemotherapy, which confirms the reliability of zFXVP and implicates the potential application of PF-502 in clinical practice as an adjuvant vascular normalization drug.

2023-09-13 | GSE224106 | GEO

Modified C-type natriuretic peptide normalizes tumor vasculature and improves solid tumor therapies

Project description:Modified C-type natriuretic peptide normalizes tumor vasculature and improves solid tumor therapies

| PRJNA1016266 | ENA

Heterogeneity of Breast Cancer Vasculature

2010-09-19 | GSE15363 | GEO

Oncofetal reprogramming in tumor development and progression: novel insights into cancer therapy.

Project description:Emerging evidence indicates that cancer cells can mimic characteristics of embryonic development, promoting their development and progression. Cancer cells share features with embryonic development, characterized by robust proliferation and differentiation regulated by signaling pathways such as Wnt, Notch, hedgehog, and Hippo signaling. In certain phase, these cells also mimic embryonic diapause and fertilized egg implantation to evade treatments or immune elimination and promote metastasis. Additionally, the upregulation of ATP-binding cassette (ABC) transporters, including multidrug resistance protein 1 (MDR1), multidrug resistance-associated protein 1 (MRP1), and breast cancer-resistant protein (BCRP), in drug-resistant cancer cells, analogous to their role in placental development, may facilitate chemotherapy efflux, further resulting in treatment resistance. In this review, we concentrate on the underlying mechanisms that contribute to tumor development and progression from the perspective of embryonic development, encompassing the dysregulation of developmental signaling pathways, the emergence of dormant cancer cells, immune microenvironment remodeling, and the hyperactivation of ABC transporters. Furthermore, we synthesize and emphasize the connections between cancer hallmarks and embryonic development, offering novel insights for the development of innovative cancer treatment strategies.

| S-EPMC10693315 | biostudies-literature

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data